Acasti Pharma reported $62.82M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Acasti Pharma USD 62.82M 732K Sep/2025
Addus HomeCare USD 1.09B 35.33M Dec/2025
Amarin USD 459.28M 387K Dec/2025
Cassava Sciences USD 74.4M 7.16M Dec/2025
Knight Therapeutics CAD 767.27M 480K Dec/2025
Option Care Health USD 1.33B 32.27M Dec/2025
Organigram Holdings CAD 369.46M 20.33M Dec/2025
Tilray USD 1.58B 39.08M Sep/2025